|
Fusion gene ID: 9175 |
FusionGeneSummary for CYP4F12_PTGER1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CYP4F12_PTGER1 | Fusion gene ID: 9175 | Hgene | Tgene | Gene symbol | CYP4F12 | PTGER1 | Gene ID | 66002 | 5731 |
Gene name | cytochrome P450 family 4 subfamily F member 12 | prostaglandin E receptor 1 | |
Synonyms | CYPIVF12|F22329_1 | EP1 | |
Cytomap | 19p13.12 | 19p13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | cytochrome P450 4F12cytochrome P450, family 4, subfamily F, polypeptide 12cytochrome P450, subfamily IVF, polypeptide 12 | prostaglandin E2 receptor EP1 subtypePGE receptor, EP1 subtypePGE2 receptor EP1 subtypeprostaglandin E receptor 1 (subtype EP1), 42kDprostaglandin E receptor 1 (subtype EP1), 42kDaprostaglandin E receptor 1, subtype EP1prostanoid EP1 receptor | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | Q9HCS2 | P34995 | |
Ensembl transtripts involved in fusion gene | ENST00000550308, ENST00000324632, | ENST00000292513, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 1 X 1 X 1=1 |
# samples | 2 | 1 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: CYP4F12 [Title/Abstract] AND PTGER1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LIHC | TCGA-RC-A6M4-01A | CYP4F12 | chr19 | 15789215 | + | PTGER1 | chr19 | 14585149 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000550308 | ENST00000292513 | CYP4F12 | chr19 | 15789215 | + | PTGER1 | chr19 | 14585149 | - |
5CDS-5UTR | ENST00000324632 | ENST00000292513 | CYP4F12 | chr19 | 15789215 | + | PTGER1 | chr19 | 14585149 | - |
Top |
FusionProtFeatures for CYP4F12_PTGER1 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CYP4F12 | PTGER1 |
Catalyzes leukotriene B4 omega-hydroxylation andarachidonic acid omega-hydroxylation but with an activity muchlower than that of CYP4F2. Catalyzes the hydroxylation of theantihistamine ebastine. | Receptor for prostaglandin E2 (PGE2). The activity ofthis receptor is mediated by G(q) proteins which activate aphosphatidylinositol-calcium second messenger system. May play arole as an important modulator of renal function. Implicated thesmooth muscle contractile response to PGE2 in various tissues. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CYP4F12_PTGER1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CYP4F12_PTGER1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CYP4F12 | SOD2, HSPA6, CYP4F2, CYP4F8, ZBTB18, POLE2 | PTGER1 | ADRB2, PTGS2 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CYP4F12_PTGER1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | PTGER1 | P34995 | DB00429 | Carboprost Tromethamine | Prostaglandin E2 receptor EP1 subtype | small molecule | approved |
Tgene | PTGER1 | P34995 | DB00917 | Dinoprostone | Prostaglandin E2 receptor EP1 subtype | small molecule | approved |
Tgene | PTGER1 | P34995 | DB00297 | Bupivacaine | Prostaglandin E2 receptor EP1 subtype | small molecule | approved|investigational |
Tgene | PTGER1 | P34995 | DB00770 | Alprostadil | Prostaglandin E2 receptor EP1 subtype | small molecule | approved|investigational |
Tgene | PTGER1 | P34995 | DB00905 | Bimatoprost | Prostaglandin E2 receptor EP1 subtype | small molecule | approved|investigational |
Tgene | PTGER1 | P34995 | DB01088 | Iloprost | Prostaglandin E2 receptor EP1 subtype | small molecule | approved|investigational |
Top |
RelatedDiseases for CYP4F12_PTGER1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | PTGER1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Tgene | PTGER1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Tgene | PTGER1 | C0020429 | Hyperalgesia | 1 | CTD_human |
Tgene | PTGER1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Tgene | PTGER1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Tgene | PTGER1 | C0237873 | Physiological Sexual Disorders | 1 | CTD_human |
Tgene | PTGER1 | C1134719 | Invasive Ductal Breast Carcinoma | 1 | CTD_human |